BENFO-TEAM

Objetivo

The BenfoTeam Study is a multi-site clinical trial evaluating whether Benfotiamine, a form of vitamin B1, can help slow memory decline and support brain health in individuals with early Alzheimer's disease. Benfotiamine is thought to enhance brain energy metabolism and reduce biological changes linked to Alzheimer's, including inflammation and abnormal protein buildup. Early research has shown it to be safe, well-tolerated, and potentially beneficial for cognition and daily function.

Palabras clave: Mild Cognitive Impairment (MCI), early AD, dementia, memory concerns

Sitios de estudio

1520 San Pablo St. Suite 3000 Los Angeles, CA 90033

 
  • Men & Women
Age icon
50 - 89
 
 
To find out if you are eligible for the study contact Carlota Conant at adrc@med.usc.edu or (323) 442-7600. 
 

Why participate?

Los avances médicos son imposibles sin voluntarios.

Elegibilidad

Criterios de inclusión

  • You are between 50 and 89 years old
  • You have been diagnosed with Mild Cognitive Impairment (MCI) or early Alzheimer's disease
  • You've noticed changes in memory or thinking, or your family and friends have observed that you seem more forgetful or less sharp than before
  • You have a study partner or caregiver who knows you well and can accompany you to study visits
  • You have been taking your usual medications at stable doses for at least 4 weeks before joining
  • You are willing and able to attend regular study visits and participate in study activities

Criterios de exclusión

    No hay criterios de exclusión.

Study Website

https://www.benfoteam.org/ 

Equipo del Programa

Photohandler
Investigador Principal
Lon Schneider, MD

For questions about this study, contact:

We respect your privacy!

Toda la información que usted nos dé será guardada en una base de datos segura y protegida. Toda la información que usted decida compartir se mantendrá de manera confidencial y privada. Lea la Política de Privacidad de la universidad University of Southern California aquí.